Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raph L Hamers

Showing results (11-20 of 144) with videos related to

Pageof 15
Sort By:
Antimicrobial Resistance and Infection Control|June 14, 2022
A qualitative study of barriers to antimicrobial stewardship in Indonesian hospitals: governance, competing interests, cost, and structural vulnerabilityRalalicia Limato, Alex Broom, Erni J Nelwan, et al.
BMJ Open|June 2, 2022
Developing a priority global research agenda for antimicrobial resistance in the human health sector: protocol for a scoping reviewRaph L Hamers, Alessandro Cassini, Koe Stella Asadinia, et al.
The Lancet. HIV|September 9, 2018
HIV drug resistance in low-income and middle-income countriesRaph L Hamers, Tobias F Rinke de Wit, Charles B Holmes
The New England Journal of Medicine|March 6, 2018
HIV Drug ResistanceSeth C Inzaule, Tobias F Rinke de Wit, Raph L Hamers
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2018
Does Tenofovir-containing First-line Antiretroviral Therapy Mitigate the Impact of Pretreatment Non-nucleoside Reverse Transcriptase Inhibitor Drug Resistance?Seth C Inzaule, Tobias F Rinke de Wit, Raph L Hamers, et al.
The Lancet. Infectious Diseases|May 31, 2013
Pretreatment HIV-1 drug resistance in AfricaRaph L Hamers, Cissy Kityo, Kim Ce Sigaloff, et al.
Frontiers in Pharmacology|July 26, 2021
Safety and Pharmacokinetic Profiles of Long-Acting Injectable Antiretroviral Drugs for HIV-1 Pre-Exposure Prophylaxis: A Systematic Review and Meta-analysis of Randomized TrialsGilbert Lazarus, Vincent Kharisma Wangsaputra, Christianto, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 4, 2015
Stringent HIV Viral Load Threshold for Virological Failure Using Dried Blood Spots: Is the Perfect the Enemy of the Good?Seth C Inzaule, Raph L Hamers, Clement E Zeh, et al.
Plos One|February 9, 2017
Correction: Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative StudySeth C Inzaule, Raph L Hamers, Cissy Kityo, et al.
Plos One|November 30, 2016
Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative StudySeth C Inzaule, Raph L Hamers, Cissy Kityo, et al.
Pageof 15

Showing results (11-20 of 144) with videos related to

Sort By:
Pageof 15
Antimicrobial Resistance and Infection Control|June 14, 2022
A qualitative study of barriers to antimicrobial stewardship in Indonesian hospitals: governance, competing interests, cost, and structural vulnerabilityRalalicia Limato, Alex Broom, Erni J Nelwan, et al.
BMJ Open|June 2, 2022
Developing a priority global research agenda for antimicrobial resistance in the human health sector: protocol for a scoping reviewRaph L Hamers, Alessandro Cassini, Koe Stella Asadinia, et al.
The Lancet. HIV|September 9, 2018
HIV drug resistance in low-income and middle-income countriesRaph L Hamers, Tobias F Rinke de Wit, Charles B Holmes
The New England Journal of Medicine|March 6, 2018
HIV Drug ResistanceSeth C Inzaule, Tobias F Rinke de Wit, Raph L Hamers
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2018
Does Tenofovir-containing First-line Antiretroviral Therapy Mitigate the Impact of Pretreatment Non-nucleoside Reverse Transcriptase Inhibitor Drug Resistance?Seth C Inzaule, Tobias F Rinke de Wit, Raph L Hamers, et al.
The Lancet. Infectious Diseases|May 31, 2013
Pretreatment HIV-1 drug resistance in AfricaRaph L Hamers, Cissy Kityo, Kim Ce Sigaloff, et al.
Frontiers in Pharmacology|July 26, 2021
Safety and Pharmacokinetic Profiles of Long-Acting Injectable Antiretroviral Drugs for HIV-1 Pre-Exposure Prophylaxis: A Systematic Review and Meta-analysis of Randomized TrialsGilbert Lazarus, Vincent Kharisma Wangsaputra, Christianto, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 4, 2015
Stringent HIV Viral Load Threshold for Virological Failure Using Dried Blood Spots: Is the Perfect the Enemy of the Good?Seth C Inzaule, Raph L Hamers, Clement E Zeh, et al.
Plos One|February 9, 2017
Correction: Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative StudySeth C Inzaule, Raph L Hamers, Cissy Kityo, et al.
Plos One|November 30, 2016
Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative StudySeth C Inzaule, Raph L Hamers, Cissy Kityo, et al.
Pageof 15